Welcome to MutualFunds.com. Please help us personalize your experience.
Thank you for your submission, we hope you enjoy your experience

Select the one that best describes you
Mutualfunds logo

SHSAX BlackRock Health Sciences Opps Inv A

  • Fund
  • SHSAX
  • Price as of: Aug 08, 2016
  • $49.09
  • - $0.40
  • - 0.81%
  • Category
  • Health & Biotech Equities

SHSAX - Profile

Vitals

  • YTD Return 1.2%
  • 3 Yr Annualized Return 17.2%
  • 5 Yr Annualized Return 19.4%
  • Net Assets $5.82 B
  • Holdings in Top 10 36.3%

52 WEEK LOW AND HIGH

$49.09
$40.74
$54.37

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.16%

SALES FEES

  • Front Load 5.25%
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 50.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

STANDARD (TAXABLE)

$1,000

IRA

$100

Investment Themes

CATEGORY

Health & Biotech Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return 1.2%
  • 3 Yr Annualized Total Return 15.1%
  • 5 Yr Annualized Total Return 18.1%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -0.19%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name BlackRock Health Sciences Opportunities Portfolio
  • Fund Family Name BlackRock
  • Inception Date Dec 21, 1999
  • Shares Outstanding N/A
  • Share Class A
  • Currency USD
  • Domiciled Country United States
  • Manager Erin Xie

Fund Description

The BlackRock Health Sciences Opportunities Fund Investor A Shares (SHSAX) is a low-cost, broad fund focused on the health care sector. SHSAX uses fundamental analysis and growth metrics when choosing its portfolio, which can include every subsector of the industry, from Big Pharma stocks to smaller medical device firms. SHSAX holds international health care stocks as well and can invest across any market-cap size.

As a broader health care fund, SHSAX can be used as a larger satellite position in an equity portfolio.

SHSAX - Performance

Return Ranking - Trailing

Period SHSAX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD 1.2% -25.2% 18.9% 13.39% 1
1 Yr -5.5% -29.1% 15.0% 16.96% 1
3 Yr 17.2% * 4.7% 22.2% 22.94% 2
5 Yr 19.4% * 10.5% 23.7% 32.38% 2
10 Yr 13.9% * 8.3% 16.3% 20.79% 1

* Annualized


Return Ranking - Calendar

Period SHSAX Return Category Return Low Category Return High Rank in Category (%) Quintile
2015 -1.8% -20.4% 13.8% 44.04% 3
2014 N/A 13.1% 21.8% N/A N/A
2013 N/A 30.6% 65.2% N/A N/A
2012 N/A 9.6% 27.7% N/A N/A
2011 N/A -1.8% 18.0% N/A N/A

Total Return Ranking - Trailing

Period SHSAX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD 1.2% -25.2% 18.9% 13.39% 1
1 Yr -10.4% -32.7% 15.0% 40.18% 2
3 Yr 15.1% * 3.2% 22.2% 35.78% 2
5 Yr 18.1% * 9.9% 23.7% 47.62% 3
10 Yr 13.3% * 8.0% 16.3% 29.70% 2

* Annualized


Total Return Ranking - Calendar

Period SHSAX Return Category Return Low Category Return High Rank in Category (%) Quintile
2015 -1.8% -20.4% 13.8% 44.04% 3
2014 N/A 17.6% 22.2% N/A N/A
2013 N/A 51.1% 71.1% N/A N/A
2012 N/A 19.8% 39.6% N/A N/A
2011 N/A 13.8% 20.1% N/A N/A

NAV & Total Return History

SHSAX - Holdings

Filings data as of: Jun 30, 2016

Concentration Analysis

SHSAX Category Low Category High SHSAX % Rank Quintile
Net Assets 5.82 B 23.8 M 50.7 B 5.36% 1
Number of Holdings 111 30 356 10.71% 2
Net Assets in Top 10 2.03 B 9.08 M 20.2 B 5.36% 1
Weighting of Top 10 36.3% 22.2% 68.4% 26.79% 4

Top 10 Holdings

  1. UnitedHealth Group Inc 6.13%
  2. Medtronic PLC 5.88%
  3. Eli Lilly and Co 3.26%
  4. Allergan PLC 3.15%
  5. Boston Scientific Corp 4.33%
  6. Amgen Inc 3.83%
  7. Johnson & Johnson 2.84%
  8. Pfizer Inc 2.55%
  9. Stryker Corp 2.20%
  10. Baxter International Inc 2.18%

Asset Allocation

Weighting Category Low Category High SHSAX % Rank Quintile
Stocks
94.88% 87.51% 106.76% 29.46% 5
Cash
3.17% 0.00% 12.50% 8.04% 2
Other
1.94% -6.76% 2.31% 3.57% 1
Convertible Bonds
0.00% 0.00% 0.33% 3.57% 1
Preferred Stocks
0.00% 0.00% 1.48% 4.46% 2
Bonds
0.00% 0.00% 1.19% 3.57% 1

Stock Sector Breakdown

Weighting Category Low Category High SHSAX % Rank Quintile
Healthcare
92.88% 14.93% 99.47% 25.00% 4
Technology
1.81% 0.00% 64.47% 11.61% 3
Consumer Cyclical
0.20% 0.00% 4.23% 4.46% 1
Financial Services
0.00% 0.00% 1.13% 6.25% 2
Real Estate
0.00% 0.00% 1.99% 1.79% 1
Industrials
0.00% 0.00% 12.74% 15.18% 3
Energy
0.00% 0.00% 0.00% 0.89% 1
Communication Services
0.00% 0.00% 2.23% 1.79% 1
Consumer Defense
0.00% 0.00% 2.38% 12.50% 3
Utilities
0.00% 0.00% 1.25% 1.79% 1
Basic Materials
0.00% 0.00% 2.05% 3.57% 1

Stock Geographic Breakdown

Weighting Category Low Category High SHSAX % Rank Quintile
US
87.95% 62.67% 99.85% 18.75% 3
Non US
6.93% 0.14% 44.09% 21.43% 4

SHSAX - Expenses

Operational Fees

SHSAX Fees (% of AUM) Category Low Category High Rank in Category (%) Quintile
Expense Ratio 1.16% 0.10% 4.31% 44.64% 2
Management Fee 0.68% 0.08% 1.25% 12.50% 2
12b-1 Fee 0.25% 0.00% 1.00% 8.97% 1
Administrative Fee 0.04% 0.01% 0.40% 15.38% 2

Sales Fees

SHSAX Fees (% of AUM) Category Low Category High SHSAX Rank Quintile
Front Load 5.25% 3.50% 5.75% 11.54% 1
Deferred Load N/A 1.00% 5.00% N/A N/A

Trading Fees

SHSAX Fees (% of AUM) Category Low Category High SHSAX Rank Quintile
Max Redemption Fee N/A 0.75% 2.00% N/A N/A

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

SHSAX Fees (% of AUM) Category Low Category High SHSAX Rank Quintile
Turnover 50.00% 4.00% 249.00% 11.61% 4

SHSAX - Distributions

Dividend Yield Analysis

SHSAX Category Low Category High SHSAX % Rank Quintile
Dividend Yield 0.0% 0.01% 0.94% 70.21% 4

Dividend Distribution Analysis

SHSAX Category Low Category High Category Mode
Dividend Distribution Frequency Annually Annually Quarterly Annually

Dividend Payout History


Net Income Ratio Analysis

SHSAX Category Low Category High SHSAX % Rank Quintile
Net Income Ratio -0.19% -2.26% 1.24% 25.00% 2

Capital Gain Distribution Analysis

SHSAX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

SHSAX - Managers

Erin Xie

Manager

Start Date

Jul 31, 2003

Tenure

13.01

Tenure Rank

5.3%

Ms. Xie is the managing director and Portfolio Manager of BlackRock Advisor since 2006. Before becoming part of BlackRock Advisors in 2005, she was with State Street Research & Management since 2001. Ms. Xie began her investment career as a pharmaceutical analyst for Sanford Bernstein in 1999.


Thomas P. Callan

Lead Manager

Start Date

Jan 31, 2005

Tenure

11.5

Tenure Rank

6.2%

Thomas P. Callan, CFA, Managing Director and senior portfolio manager, is head of BlackRock's Global Opportunities equity team. He oversees the team's investment process, leads the team's Investment Strategy Group, and provides portfolio and risk management oversight for all of the team's products. In addition, Mr. Callan is a member of BlackRock's Leadership Committee. Mr. Callan's service with the firm dates back to 1988, including his years with PNC Asset Management Group, which was integrated with BlackRock in 1998. He started as a health care analyst for PNC's mutual fund group and later served as an international equity analyst. Mr. Callan began his investment career at PNC Bank as a personal trust portfolio manager in 1988. Mr. Callan earned a BA degree in economics, with honors, from Boston College in 1981.


Tenure Analysis

Category Low

0.1

Category High

18.9

Category Average

8.99

Category Mode

1.6